<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36862854</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Prevalence of fatigue functional and social impairment among patients with rheumatic diseases compared to patients without: A cross-sectional comparison.</ArticleTitle><Pagination><StartPage>e33151</StartPage><MedlinePgn>e33151</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33151</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033151</ELocationID><Abstract><AbstractText>Rheumatic diseases (RD) are chronic diseases that significantly affect the lives of patients. Assessing health outcomes through a patient-reported outcome measurement information system (PROMIS) is essential for RD management. Moreover, these tend to be less favorable among individuals than among the rest of the population. This study aimed to compare PROMIS between RD patients and other patients. This cross sectional study was conducted in the year 2021. Information about patients with RD was obtained from the RD registry at King Saud University Medical City. Patients without RD were recruited from family medicine clinics. Patients were contacted electronically through WhatsApp&#xa9; to complete the PROMIS surveys. We compared the individual PROMIS scores between the 2 groups using linear regression, adjusting for sex, nationality, marital status, education level, employment, family history of RD, income, and chronic comorbidities. There were 1024 individuals (512 with RD and 512 without RD). The most common RD was systemic lupus erythematosus (51.6%), followed by rheumatoid arthritis (44.3%). Individuals with RD reported significantly higher PROMIS T-scores for pain [&#x3b2; = 6.2; 95% confidence interval (CI) = 4.76, 7.71] and fatigue (&#x3b2; = 2.9; 95% CI = 1.37, 4.38) compared to those without RD. Moreover, RD individuals reported lower physical functioning (&#x3b2; = -5.4; 95% CI = -6.50, -4.24) and social interaction (&#x3b2; = -4.5; 95% CI = -5.73, -3.20). Patients with RD in Saudi Arabia, particularly those with systemic lupus erythematosus and rheumatoid arthritis, have significantly greater impairment in physical functioning and social interaction and report higher levels of fatigue and pain. Addressing and ameliorating these negative outcomes is necessary to improve quality of life.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almalag</LastName><ForeName>Haya M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almaghlouth</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabbagh</LastName><ForeName>Rufaidah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsalem</LastName><ForeName>Abdulaziz R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrajban</LastName><ForeName>Fahad N</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Algarni</LastName><ForeName>Saleh A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alosaimi</LastName><ForeName>Faisal N</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alassaf</LastName><ForeName>Meshal I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshamrani</LastName><ForeName>Muhammad A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzomia</LastName><ForeName>Sulaiman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Boshra</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alalwan</LastName><ForeName>Tareq</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkhalaf</LastName><ForeName>Abdulaziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedaiwi</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omair</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36862854</ArticleId><ArticleId IdType="pmc">PMC9981388</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033151</ArticleId><ArticleId IdType="pii">00005792-202303030-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2016;3:151&#x2013;5.</Citation></Reference><Reference><Citation>Choi ST, Kang JI, Park I-H, et al. . Subscale analysis of quality of life in patients with systemic lupus erythematosus: association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol. 2012;30:665&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">22704691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira MG, Duarte S, Ferraz A, et al. . Quality of life in patients with systemic lupus erythematosus: the mediator role of psychological morbidity and disease activity. Psychol Health Med. 2020;25:1247&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">32093519</ArticleId></ArticleIdList></Reference><Reference><Citation>Macejov&#xe1; Z, Z&#xe1;rikov&#xe1; M, Oetterov&#xe1; M. Systemic Lupus Erythematosus - Disease impact on patients. Cent Eur J Public Health. 2013;21:171&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">24344545</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AS, Gulliver WP, Iriven EJ, et al. . Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl. 2011;88:7&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">22045973</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo-Braga M, Cornaby C, Cortez A, et al. . Depression and anxiety in systemic lupus erythematosus. Medicine (Baltim). 2018;97:e11376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076116</ArticleId><ArticleId IdType="pubmed">29995777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossec L. Patient-reported outcomes in rheumatoid arthritis: why are they important and how should they be assessed? Turkish J Rheumatol. 2010;25:99&#x2013;104.</Citation></Reference><Reference><Citation>Nagaraja V, Mara C, Khanna PP, et al. . Establishing clinical severity for PROMIS&#xae; measures in adult patients with rheumatic diseases. Qual Life Res. 2018;27:755&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845827</ArticleId><ArticleId IdType="pubmed">28983738</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dalaan A, Al Ballaa S, Bahabri S, et al. . The prevalence of rheumatoid arthritis in the Qassim Region of Saudi Arabia. Ann Saudi Med. 1998;18:396&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17344708</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. . Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J. 2002;23:87&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11938371</ArticleId></ArticleIdList></Reference><Reference><Citation>Omair MA, Alshehri MM, Altokhais NA, et al. . Exploring factors influencing medication compliance in saudi rheumatoid arthritis patients: a nationwide cross-sectional survey - results from the COPARA study. Patient Prefer Adherence. 2022;16:1105&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9056069</ArticleId><ArticleId IdType="pubmed">35502428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassen LM, Almaghlouth IA, Hassen IM, et al. . Impact of COVID-19 outbreak on rheumatic patients&#x2019; perceptions and behaviors: a cross-sectional study. Int J Rheum Dis. 2020;23:1541&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32940963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassen LM, Albarrak RA, Albahlal RA, et al. . Functional and psychosocial impact of COVID-19 pandemic on rheumatic patients&#x2019; quality of life in Saudi Arabia. Qual Life Res. 2022;31:3229&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297668</ArticleId><ArticleId IdType="pubmed">35857205</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Riley W, Stone A, et al. . The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965562</ArticleId><ArticleId IdType="pubmed">20685078</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM Corp. Released 2021. IBM SPSS Statistics for Windows 28.0. Armonk, NY: IBM Corp; 2021.</Citation></Reference><Reference><Citation>Izadi Z, Li J, Evans M, et al. . Socioeconomic disparities in functional status in a national sample of patients with rheumatoid arthritis. JAMA Netw Open. 2021;4:e2119400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339935</ArticleId><ArticleId IdType="pubmed">34347058</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips K, Clauw DJ. Review: central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum. 2013;65:291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610409</ArticleId><ArticleId IdType="pubmed">23045168</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10:777&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741022</ArticleId><ArticleId IdType="pubmed">19638325</ArticleId></ArticleIdList></Reference><Reference><Citation>Santo RC do E, Baker JF, Dos Santos LP, et al. . Changes in physical function over time in rheumatoid arthritis patients: a cohort study. PLoS One. 2023;18:e0280846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9870154</ArticleId><ArticleId IdType="pubmed">36689423</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Garc&#xed;a E, Barnes-Ortiz S, P&#xe9;rez-M&#xe1;rmol JM. Self-efficacy, pain intensity, rheumatic disease duration, and hand functional disability on activities of daily living. Nurs Res. 2020;69:E208&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">32804710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawka L, Schlencker A, Mertz P, et al. . Fatigue in systemic lupus erythematosus: an update on its impact, determinants and therapeutic management. J Clin Med. 2021;10:3996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8432566</ArticleId><ArticleId IdType="pubmed">34501444</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterling K, Gallop K, Swinburn P, et al. . Patient-reported fatigue and its impact on patients with systemic lupus erythematosus. Lupus. 2014;23:124&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">24197552</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>